Log In
BCIQ
Print this Print this
 

CR6086

  Manage Alerts
Collapse Summary General Information
Company Rottapharm Biotech s.r.l.
DescriptionProstaglandin EP4 receptor antagonist
Molecular Target Prostaglandin E2 (PGE2) receptor EP4 subtype (Prostanoid EP4 receptor) (PTGER4)
Mechanism of ActionProstaglandin E2 receptor EP4 antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today